These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 12423714

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P.
    Circulation; 2001 Feb 27; 103(8):1083-8. PubMed ID: 11222470
    [Abstract] [Full Text] [Related]

  • 3. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.
    Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P.
    Lancet; 1998 Apr 11; 351(9109):1091-3. PubMed ID: 9660578
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.
    Bahrmann P, Hengst UM, Richartz BM, Figulla HR.
    Eur J Heart Fail; 2004 Mar 01; 6(2):195-201. PubMed ID: 14984727
    [Abstract] [Full Text] [Related]

  • 5. Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.
    Skudicky D, Sliwa K, Bergemann A, Candy G, Sareli P.
    Heart; 2000 Oct 01; 84(4):438-9. PubMed ID: 10995419
    [No Abstract] [Full Text] [Related]

  • 6. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study.
    Sliwa K, Woodiwiss A, Kone VN, Candy G, Badenhorst D, Norton G, Zambakides C, Peters F, Essop R.
    Circulation; 2004 Feb 17; 109(6):750-5. PubMed ID: 14970111
    [Abstract] [Full Text] [Related]

  • 7. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E, Kurum T.
    Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O'Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR.
    Am J Med; 1990 Mar 15; 88(3):223-9. PubMed ID: 1968710
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy.
    Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M, Karavolias G, Mitropoulos D, Degiannis D, Kremastinos DT.
    Eur Heart J; 2003 Dec 15; 24(24):2186-96. PubMed ID: 14659770
    [Abstract] [Full Text] [Related]

  • 12. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.
    Lauterbach R, Pawlik D, Kowalczyk D, Ksycínski W, Helwich E, Zembala M.
    Crit Care Med; 1999 Apr 15; 27(4):807-14. PubMed ID: 10321674
    [Abstract] [Full Text] [Related]

  • 13. Pentoxifylline for heart failure: a systematic review.
    Batchelder K, Mayosi BM.
    S Afr Med J; 2005 Mar 15; 95(3):171-5. PubMed ID: 15832667
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study.
    Zeni F, Pain P, Vindimian M, Gay JP, Gery P, Bertrand M, Page Y, Page D, Vermesch R, Bertrand JC.
    Crit Care Med; 1996 Feb 15; 24(2):207-14. PubMed ID: 8605790
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
    Adamopoulos S, Parissis JT, Georgiadis M, Karatzas D, Paraskevaidis J, Kroupis C, Karavolias G, Koniavitou K, Kremastinos DT.
    Am Heart J; 2002 Aug 15; 144(2):359-64. PubMed ID: 12177657
    [Abstract] [Full Text] [Related]

  • 18. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR.
    Am J Cardiol; 1996 Oct 01; 78(7):779-84. PubMed ID: 8857482
    [Abstract] [Full Text] [Related]

  • 19. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy.
    Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P.
    Eur J Heart Fail; 2002 Jun 01; 4(3):305-9. PubMed ID: 12034156
    [Abstract] [Full Text] [Related]

  • 20. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F, Strömblad O, Andersson B, Böhm M, Darius M, Delius W, Goss F, Osterziel KJ, Sigmund M, Trenkwalder SP, Wahlqvist I.
    Eur J Heart Fail; 2003 Oct 01; 5(5):679-91. PubMed ID: 14607208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.